JPWO2025159067A5 - - Google Patents

Info

Publication number
JPWO2025159067A5
JPWO2025159067A5 JP2025546071A JP2025546071A JPWO2025159067A5 JP WO2025159067 A5 JPWO2025159067 A5 JP WO2025159067A5 JP 2025546071 A JP2025546071 A JP 2025546071A JP 2025546071 A JP2025546071 A JP 2025546071A JP WO2025159067 A5 JPWO2025159067 A5 JP WO2025159067A5
Authority
JP
Japan
Prior art keywords
promoter
nucleic acid
oncolytic virus
acid encoding
cxcl10
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025546071A
Other languages
English (en)
Japanese (ja)
Other versions
JP7816735B2 (ja
JPWO2025159067A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2025/001686 external-priority patent/WO2025159067A1/ja
Publication of JPWO2025159067A1 publication Critical patent/JPWO2025159067A1/ja
Publication of JPWO2025159067A5 publication Critical patent/JPWO2025159067A5/ja
Application granted granted Critical
Publication of JP7816735B2 publication Critical patent/JP7816735B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2025546071A 2024-01-22 2025-01-21 腫瘍溶解性ウイルス及びそれを用いたがん治療 Active JP7816735B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2024007682 2024-01-22
JP2024007682 2024-01-22
PCT/JP2025/001686 WO2025159067A1 (ja) 2024-01-22 2025-01-21 腫瘍溶解性ウイルス及びそれを用いたがん治療

Publications (3)

Publication Number Publication Date
JPWO2025159067A1 JPWO2025159067A1 (https=) 2025-07-31
JPWO2025159067A5 true JPWO2025159067A5 (https=) 2025-12-23
JP7816735B2 JP7816735B2 (ja) 2026-02-18

Family

ID=96545359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025546071A Active JP7816735B2 (ja) 2024-01-22 2025-01-21 腫瘍溶解性ウイルス及びそれを用いたがん治療

Country Status (3)

Country Link
JP (1) JP7816735B2 (https=)
TW (1) TW202546223A (https=)
WO (1) WO2025159067A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7117087B2 (ja) * 2017-07-10 2022-08-12 株式会社Ｉｄファーマ 癌の治療組成物
CN111542601A (zh) * 2017-11-08 2020-08-14 国立大学法人鹿儿岛大学 确保安全并且能够有效地治疗甚至转移性癌症的、具有提供装载的免疫诱导基因的最佳表达水平的表达控制系统的肿瘤溶解性病毒(肿瘤溶解性免疫治疗)
EP3731850A4 (en) * 2017-12-29 2021-12-01 Oncorus, Inc. ONCOLYTIC VIRUS DELIVERY OF THERAPEUTIC POLYPEPTIDES
US20220251604A1 (en) * 2019-06-14 2022-08-11 Tilt Biotherapeutics Oy Oncolytic adenovirus and checkpoint inhibitor combination therapy
CN114364792B (zh) * 2019-08-09 2024-10-01 Km生物医药股份公司 溶瘤牛痘病毒

Similar Documents

Publication Publication Date Title
JP4874247B2 (ja) 腫瘍溶解性アデノウイルス組換え体、特に、腫瘍において免疫調節因子ｇｍ−ｃｓｆを発現する組換え体の構築およびその利用
JP2023012463A5 (https=)
JP5097714B2 (ja) Ｅ１領域内の発現カセットと不活性化されたｅ２ｂポリメラーゼを有するアデノウイルス発現ベクター
US6767699B2 (en) Method for the quantitation of alphavirus replicon particles
HU221275B1 (en) Replication defective recombinant adenoviruses expressing anti-tumor cytokines, process for production thereof and their uses
JP3875990B2 (ja) 組換えアデノウイルスベクターおよび使用方法
EP0791050B1 (en) Vectors for tissue-specific replication
ES2264123T3 (es) Adenovirus recombinantes defectivos para la terapia genica de tumores.
US20080103109A1 (en) Vectors for tissue-specific replication
EP1032696A1 (en) Vector for tissue-specific replication and gene expression
JP2023528371A5 (https=)
JPWO2025159067A5 (https=)
CN101092636B (zh) 选择性复制的病毒载体和其制备方法及应用
Lui et al. Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo
JP2025084850A5 (https=)
CN102985094B (zh) 一种重组肿瘤疫苗及其生产方法
JP2003189887A5 (https=)
JP2024502620A5 (https=)
Brack et al. Hematopoietic growth factors: interactions and regulation of production
Wu et al. Viral delivery for gene therapy against cell movement in cancer
JP2006511212A5 (https=)
JP2008508899A5 (https=)
CN118853767A (zh) 一种新型溶瘤腺病毒载体及其构建方法和应用
AU714867B2 (en) Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating
JP2022513347A5 (https=)